Internal Medicine, Pulmonary Disease · Kearny, NJ
NPI
1568401636
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
221 Kearny Ave
Kearny, NJ, 07032
Phone (201) 997-0808
Groups this clinician bills Medicare through
Medicare paid, 2024
$245K
4,164 services
Medicare patients, 2024
311
Average age 76
Drug cost, 2024
$2.4M
7,153 prescriptions
Company payments, 2025
$15K
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Viren Desai was code 99214 (office e&m - established), 737 times for 225 patients. In total Viren Desai billed 4,164 services in 39 codes, and Medicare paid $245K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-02-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 737 | 225 | $108.85 | $80K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 481 | 49 | $0.78 | $377 |
| 99233 Hospital E&M - Subsequent | Facility | 396 | 58 | $99.93 | $40K |
| 94060 Pulmonary Function Testing | Office | 354 | 184 | $34.79 | $12K |
| 94640 Treatment - Miscellaneous | Office | 347 | 183 | $7.27 | $2,521 |
| 94729 Pulmonary Function Testing | Office | 308 | 180 | $51.08 | $16K |
| 94727 Pulmonary Function Testing | Office | 308 | 180 | $39.81 | $12K |
| 99213 Office E&M - Established | Office | 260 | 113 | $74.46 | $19K |
| 95012 Pulmonary | Office | 242 | 145 | $17.35 | $4,199 |
| 99291 Critical Care E&M | Facility | 84 | 17 | $178.50 | $15K |
| 99223 Hospital E&M - Initial | Facility | 73 | 53 | $145.93 | $11K |
| 96372 Injection Administration | Office | 71 | 49 | $12.60 | $895 |
| 94621 Pulmonary Function Testing | Office | 70 | 60 | $137.19 | $9,603 |
| 94375 Pulmonary Function Testing | Office | 68 | 58 | $34.76 | $2,363 |
| 94618 Pulmonary Function Testing | Office | 38 | 33 | $29.67 | $1,127 |
By year: 2022 $321K for 5,106 services; 2023 $260K for 4,525 services; 2024 $245K for 4,164 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 49 | 45 | $8.40 | $412 |
Medicare prescription drug claims, 2024
In 2024, the drug Viren Desai prescribed most often to Medicare patients was Breztri Aerosphere (Budesonide/Glycopyr/Formoterol), with 798 prescriptions and refills. In total Viren Desai wrote 7,153 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 798 | 1,184 | 224 | $734K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 738 | 955 | 257 | $20K |
| Atorvastatin Calcium Generic | 426 | 1,186 | 131 | $3,738 |
| Montelukast Sodium Generic | 332 | 891 | 116 | $4,559 |
| Prednisone Generic | 301 | 336 | 174 | $542 |
| Levothyroxine Sodium Generic | 213 | 574 | 60 | $1,276 |
| Amlodipine Besylate Generic | 182 | 524 | 63 | $935 |
| Azithromycin Generic | 172 | 176 | 123 | $632 |
| Metformin Hcl Generic | 157 | 394 | 46 | $920 |
| Metoprolol Succinate Generic | 126 | 343 | 39 | $2,286 |
| Losartan Potassium Generic | 123 | 344 | 38 | $847 |
| Symbicort Budesonide/Formoterol Fumarate | 111 | 135 | 33 | $30K |
| Losartan-Hydrochlorothiazide Losartan/Hydrochlorothiazide | 89 | 253 | 25 | $1,287 |
| Breo Ellipta Fluticasone/Vilanterol | 85 | 142 | 23 | $55K |
| Januvia Sitagliptin Phosphate | 84 | 170 | 22 | $93K |
Brand drugs: 2,288 claims; generic drugs: 4,824 claims; opioid claims: 16.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Viren Desai $15K ($15K in general payments such as food, travel and fees) from 10 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $14K.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 40 | $14K |
| Genzyme Corporation SNY | 8 | $229 |
| Merz North America, Inc. | 1 | $134 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $107 |
| Sanofi-Aventis U.S. LLC SNY | 1 | $78.99 |
| Amgen Inc. AMGN | 3 | $45.7 |
| Lilly USA, LLC LLY | 3 | $44.74 |
| Verona Pharma, Inc. VRNA | 2 | $33.86 |
| United Therapeutics Corporation UTHR | 2 | $33.74 |
| Insmed, Inc. INSM | 2 | $33.38 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.